Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 277-288 of 10101

PR Newswire associated0

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

PR Newswire associated0

Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations

PR Newswire associated0

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

PR Newswire associated0

The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24

SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity

Business Wire logo

Blue Matter Launches Behavioral Science Center of Excellence to Decode and Predict Health Care Decisions in a Rapidly Evolving Biopharma Landscape

Visioneering Technologies' New Contact Lens Trial Shows Landmark Results in Slowing Children's Nearsightedness

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in Europe

PR Newswire associated0

Servier Adopts Veeva OpenData Globally to Scale AI

New Neutrogena science showcased at EADV 2026 in Vienna, Austria

Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Business Wire logo

Compass Pathways Appoints Kelley Boucher as Chief People Officer

  • Prev Page
  • 1
  • 2
  • …
  • 23
  • 24
  • 25
  • …
  • 841
  • 842
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us